Upgrade to SI Premium - Free Trial

Ironwood Pharma (IRWD)

3.31 -0.09 (2.65%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/6/26)

Latest Headlines

Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference May 28, 2026 4:05 PM - BizWire FDA approves LINZESS for children ages 2-5 with functional constipation May 27, 2026 10:00 AM - StreetInsider FDA Approves Use of LINZESS® (linaclotide) in Pediatric Patients Two Years of Age and Older with Functional Constipation (FC) May 27, 2026 10:00 AM - BizWire Form 8-K/A IRONWOOD PHARMACEUTICALS For: May 08 May 21, 2026 4:06 PM - SEC Filing Form 4 IRONWOOD PHARMACEUTICALS For: May 19 Filed by: Silver Ronald May 21, 2026 4:06 PM - SEC Filing Form SCHEDULE 13G/A IRONWOOD PHARMACEUTICALS Filed by: ARMISTICE CAPITAL, LLC May 15, 2026 11:25 AM - SEC Filing Form SCHEDULE 13G/A IRONWOOD PHARMACEUTICALS Filed by: RENAISSANCE TECHNOLOGIES LLC May 14, 2026 4:46 PM - SEC Filing Form 8-K IRONWOOD PHARMACEUTICALS For: May 08 May 13, 2026 8:01 AM - SEC Filing Form 10-Q IRONWOOD PHARMACEUTICALS For: Mar 31 May 7, 2026 4:10 PM - SEC Filing Ironwood Pharma (IRWD) Tops Q1 EPS by 5c, provides guidance May 7, 2026 7:21 AM - StreetInsider Form 8-K IRONWOOD PHARMACEUTICALS For: May 07 May 7, 2026 7:10 AM - SEC Filing Ironwood Pharmaceuticals Reports Strong First Quarter 2026 Results With 97% Year-Over-Year LINZESS U.S. Net Sales Growth; Maintains Full-Year 2026 Financial Guidance May 7, 2026 7:05 AM - BizWire Ironwood Survey Findings at DDW 2026 Underscore Need for Therapies that Address Multiple Dimensions of Total Parenteral Nutrition (TPN) Burden in Short Bowel Syndrome (SBS) May 4, 2026 7:05 AM - BizWire Ironwood Pharmaceuticals to Host First Quarter 2026 Investor Update Call April 30, 2026 4:05 PM - BizWire Form ARS IRONWOOD PHARMACEUTICALS For: Dec 31 April 28, 2026 4:12 PM - SEC Filing Form DEFA14A IRONWOOD PHARMACEUTICALS April 28, 2026 4:10 PM - SEC Filing Form DEF 14A IRONWOOD PHARMACEUTICALS For: Jun 16 April 28, 2026 4:07 PM - SEC Filing Form SCHEDULE 13G/A IRONWOOD PHARMACEUTICALS Filed by: BANK OF AMERICA CORP /DE/ April 27, 2026 12:59 PM - SEC Filing Ironwood Pharmaceuticals to Share Real-World HCP Perspectives on Burden of Total Parenteral Nutrition in Short Bowel Syndrome (SBS) at Digestive Disease Week® 2026 April 23, 2026 7:05 AM - BizWire Form SCHEDULE 13G/A IRONWOOD PHARMACEUTICALS Filed by: VANGUARD GROUP INC March 27, 2026 9:52 AM - SEC Filing Form SCHEDULE 13D/A IRONWOOD PHARMACEUTICALS Filed by: Sarissa Capital Management LP March 19, 2026 6:35 PM - SEC Filing Form 4 IRONWOOD PHARMACEUTICALS For: Mar 13 Filed by: DENNER ALEXANDER J March 17, 2026 8:35 PM - SEC Filing Form 4 IRONWOOD PHARMACEUTICALS For: Mar 10 Filed by: John Minardo March 12, 2026 4:06 PM - SEC Filing Form 4 IRONWOOD PHARMACEUTICALS For: Mar 10 Filed by: Martini Gregory S. March 12, 2026 4:06 PM - SEC Filing Form 4 IRONWOOD PHARMACEUTICALS For: Mar 10 Filed by: Shetzline Michael March 12, 2026 4:06 PM - SEC Filing Form 4 IRONWOOD PHARMACEUTICALS For: Mar 10 Filed by: Silver Ronald March 12, 2026 4:06 PM - SEC Filing Form 4 IRONWOOD PHARMACEUTICALS For: Mar 10 Filed by: Gaskins Tammi L March 12, 2026 4:05 PM - SEC Filing Form 4 IRONWOOD PHARMACEUTICALS For: Mar 10 Filed by: MCCOURT Thomas A March 12, 2026 4:05 PM - SEC Filing Form 8-K IRONWOOD PHARMACEUTICALS For: Mar 10 March 11, 2026 7:06 AM - SEC Filing Full Article List